Sanofi | SNY - Gross Profit On Sales

Stock Price
47.22
Daily Change
0.40 0.85%
Monthly
6.47%
Yearly
-7.76%
Q2 Forecast
46.65

Sanofi reported EUR8.45B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Amgen USD 6.48B 307M Sep/2025
AstraZeneca USD 12.39B 5M Dec/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Canopy Growth CAD 21.47M 434K Dec/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Drreddys Laboratories INR 46.81B 10.24B Dec/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 977M 13M Dec/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
J&J USD 16.6B 118M Dec/2025
Merck USD 13.42B 431M Sep/2025
Novartis USD 10.25B 570M Dec/2025
Novartis USD 10.82B 694M Sep/2025
Pacira USD 142.25M 11.34M Dec/2025
Perrigo USD 362.2M 14.9M Dec/2025
Pfizer USD 3.54B 7.61B Sep/2025
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Sanofi EUR 8.45B 3.02B Dec/2025
Supernus Pharmaceuticals USD 164.04M 15.23M Dec/2025
UCB EUR 3.19B 621M Dec/2025
Zoetis USD 1.64B 73M Dec/2025